comparemela.com

Latest Breaking News On - Metropolitan life insurance - Page 13 : comparemela.com

IDEAYA Biosciences (NASDAQ:IDYA) PT Raised to $35 00

IDEAYA Biosciences (NASDAQ:IDYA – Get Free Report) had its price objective raised by equities research analysts at Oppenheimer from $30.00 to $35.00 in a research report issued on Friday, MarketBeat.com reports. The firm currently has an “outperform” rating on the stock. Oppenheimer’s target price suggests a potential upside of 39.39% from the stock’s previous close. […]

Integral Health Asset Management LLC Acquires 10,000 Shares of Revance Therapeutics, Inc (NASDAQ:RVNC)

Integral Health Asset Management LLC boosted its holdings in Revance Therapeutics, Inc. (NASDAQ:RVNC – Free Report) by 4.2% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 250,000 shares of the biopharmaceutical company’s stock after buying an additional 10,000 shares during the period. […]

Green Plains (NASDAQ:GPRE) Price Target Lowered to $32 00 at Stephens

Green Plains (NASDAQ:GPRE – Free Report) had its price objective lowered by Stephens from $37.00 to $32.00 in a research note published on Monday morning, Marketbeat reports. The firm currently has an equal weight rating on the specialty chemicals company’s stock. Several other research analysts have also weighed in on GPRE. Bank of America assumed […]

Mint Tower Capital Management B V Invests $1 98 Million in ForgeRock, Inc (NYSE:FORG)

Mint Tower Capital Management B V Invests $1 98 Million in ForgeRock, Inc (NYSE:FORG)
modernreaders.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from modernreaders.com Daily Mail and Mail on Sunday newspapers.

IDEAYA Biosciences (NASDAQ:IDYA) Now Covered by Analysts at SVB Leerink

SVB Leerink started coverage on shares of IDEAYA Biosciences (NASDAQ:IDYA – Free Report) in a research report report published on Tuesday morning, Benzinga reports. The brokerage issued an outperform rating and a $33.00 target price on the stock. A number of other equities analysts have also weighed in on the stock. The Goldman Sachs Group […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.